Lisa Maher

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. ncbi Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, St Vincent s Medical Centre, 376 Victoria Street, Darlinghurst, Sydney, NSW 10, Australia
    Drug Alcohol Depend 89:244-50. 2007
  2. ncbi Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugs
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Int J Drug Policy 21:194-201. 2010
  3. ncbi Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia
    L Maher
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Int J Drug Policy 22:203-9. 2011
  4. ncbi Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research, School of Public Health and Community Medicine, University of New South Wales, Centre for Immunology, Darlinghurst, NSW 2010, Australia
    Vaccine 28:7273-8. 2010
  5. ncbi Scaling up HIV treatment, care and support for injecting drug users in Vietnam
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Int J Drug Policy 18:296-305. 2007
  6. ncbi The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006
    Heather F Gidding
    National Centre in HIV Epidemiology and Clinical Research, Darlinghurst, NSW 2010, Australia
    J Gastroenterol Hepatol 24:1648-54. 2009
  7. ncbi Acceptability of hepatitis C virus testing methods among injecting drug users
    Bethany White
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    Drug Alcohol Rev 27:666-70. 2008
  8. ncbi Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey
    Libby Topp
    Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia
    J Acquir Immune Defic Syndr 47:632-8. 2008
  9. ncbi Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004
    Kathleen Falster
    National Centre in HIV Epidemiology and Clinical Research, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    J Urban Health 86:106-18. 2009
  10. ncbi High hepatitis C incidence in new injecting drug users: a policy failure?
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney
    Aust N Z J Public Health 31:30-5. 2007

Detail Information

Publications58

  1. ncbi Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, St Vincent s Medical Centre, 376 Victoria Street, Darlinghurst, Sydney, NSW 10, Australia
    Drug Alcohol Depend 89:244-50. 2007
    ....
  2. ncbi Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugs
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Int J Drug Policy 21:194-201. 2010
    ..Feasibility studies are an important component of preparations for field trials of biomedical prevention interventions, including vaccines...
  3. ncbi Amphetamine-type stimulant use and HIV/STI risk behaviour among young female sex workers in Phnom Penh, Cambodia
    L Maher
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Int J Drug Policy 22:203-9. 2011
    ..In Cambodia, recent ATS use is independently associated with incident STI infection among young female sex workers (FSWs)...
  4. ncbi Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research, School of Public Health and Community Medicine, University of New South Wales, Centre for Immunology, Darlinghurst, NSW 2010, Australia
    Vaccine 28:7273-8. 2010
    ..Significant biological and social factors and differences between HIV and HCV suggest that HCV warrants targeted vaccine preparedness research to lay the groundwork for successful implementation of future trials...
  5. ncbi Scaling up HIV treatment, care and support for injecting drug users in Vietnam
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Int J Drug Policy 18:296-305. 2007
    ....
  6. ncbi The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006
    Heather F Gidding
    National Centre in HIV Epidemiology and Clinical Research, Darlinghurst, NSW 2010, Australia
    J Gastroenterol Hepatol 24:1648-54. 2009
    ..The aim of this study was to examine trends in the epidemiology and treatment of HCV in Australia...
  7. ncbi Acceptability of hepatitis C virus testing methods among injecting drug users
    Bethany White
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    Drug Alcohol Rev 27:666-70. 2008
    ..The aim of the current study was to determine the acceptability of three methods of hepatitis C virus (HCV) testing among injecting drug users (IDUs): oral fluid, capillary blood and venous blood sampling...
  8. ncbi Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey
    Libby Topp
    Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia
    J Acquir Immune Defic Syndr 47:632-8. 2008
    ..This study examined the representativeness of NSP Survey samples...
  9. ncbi Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004
    Kathleen Falster
    National Centre in HIV Epidemiology and Clinical Research, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    J Urban Health 86:106-18. 2009
    ..In summary, our findings suggest a persistent HCV epidemic despite significant harm reduction efforts in Australia since the mid-1980s, with HIV incidence effectively constant in successive initiation cohorts...
  10. ncbi High hepatitis C incidence in new injecting drug users: a policy failure?
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney
    Aust N Z J Public Health 31:30-5. 2007
    ..This study aimed to determine incidence of HCV and associated risk factors among new IDUs in Sydney...
  11. ncbi Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs
    James Ward
    The Kirby Institute, University of New South Wales, 45 Beach Street, Coogee, NSW 2010
    Aust N Z J Public Health 35:421-6. 2011
    ..To compare prevalence of hepatitis C virus (HCV) antibody and associated risk behaviours among Indigenous and non-Indigenous participants in the Australian Needle and Syringe Program Survey...
  12. ncbi Learning from the past: young Indigenous people's accounts of blood-borne viral and sexually transmitted infections as resilience narratives
    Julie Mooney-Somers
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, New South Wales, Australia
    Cult Health Sex 13:173-86. 2011
    ....
  13. ncbi Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia
    Rachel M Deacon
    Sydney Medical School, The University of Sydney, Sydney, NSW, Australia
    J Urban Health 89:769-78. 2012
    ..The lack of an association between incarceration and vaccination also suggests increasing vaccination uptake and completion in adult and juvenile correctional facilities may also be important...
  14. ncbi Disproportionate impact of combination antiretroviral therapy on AIDS incidence in Australia: results from a modified back-projection model
    Handan Wand
    The Kirby Institute, UNSW Cliffbrook Campus, Sydney, NSW, Australia
    AIDS Behav 16:360-7. 2012
    ..The impact of cART on AIDS diagnoses has been modest among IDUs. Late presentation, poor access to health services and barriers to uptake of cART may account for the divergence between these population groups...
  15. ncbi Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008
    Jenny Iversen
    Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    Int J Drug Policy 21:471-6. 2010
    ..This study aims to assess gender differences in hepatitis C antibody prevalence and associated risk behaviours amongst a large sample of PWID in Australia...
  16. ncbi Injecting-related injury and disease among clients of a supervised injecting facility
    Allison M Salmon
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, New South Wales, Australia
    Drug Alcohol Depend 101:132-6. 2009
    ..The social and physical environments in which drugs are injected play a significant role in these and other morbidities. Supervised injecting facilities (SIFs) seek to address such issues associated with public injecting drug use...
  17. ncbi Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users
    Heidi Coupland
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Australia
    Health Promot J Austr 20:234-40. 2009
    ..Little is known about barriers to treatment uptake among culturally diverse groups of IDUs. Indo-Chinese IDUs represent a marginalised group with high rates of incident and prevalent HCV infection...
  18. ncbi Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning
    Handan Wand
    National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
    Addiction 104:2049-56. 2009
    ..To determine risk factors and estimate their population-level contribution to hepatitis C virus (HCV) burden...
  19. ncbi The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia
    Allison M Salmon
    National Centre HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW, Australia
    Addiction 105:676-83. 2010
    ....
  20. ncbi Enhancing Aboriginal and Torres Strait Islander young people's resilience to blood-borne and sexually transmitted infections: findings from a community-based participatory research project
    Julie Mooney-Somers
    National Centre in HIV Epidemiology and Clinical Medicine, University of New South Wales, Sydney, Australia
    Health Promot J Austr 20:195-201. 2009
    ....
  21. ncbi Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs
    Ju Nyeong Park
    The Kirby Institute, University of New South Wales, Centre for Immunology, Cnr Boundary and West Streets, Darlinghurst, NSW 2010, Australia
    Drug Alcohol Depend 123:35-40. 2012
    ..However, little is known about the factors that influence willingness to participate (WTP) in candidate HCV vaccine trials among this group...
  22. ncbi Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Addiction 101:1499-508. 2006
    ..To determine the incidence of hepatitis C virus (HCV) infection and identify risk factors for seroconversion...
  23. ncbi High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre
    Allison M Salmon
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    Aust N Z J Public Health 33:280-3. 2009
    ..Measure the self-reported prevalence of HIV, history of HIV testing and associated risk factors among injecting drug users (IDUs) attending the Sydney Medically Supervised Injecting Centre (MSIC)...
  24. ncbi The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis
    Jisoo A Kwon
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, New South Wales, Australia
    J Acquir Immune Defic Syndr 51:462-9. 2009
    ..We aim to estimate how changes in sterile syringe distribution through needle-syringe programs (NSPs) may affect HIV and hepatitis C virus (HCV) incidence among injecting drug users (IDUs) in Australia...
  25. ncbi Condom negotiation across different relationship types by young women engaged in sex work in Phnom Penh, Cambodia
    Lisa Maher
    Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    Glob Public Health 8:270-83. 2013
    ..The lack of improvement in condom use in FSWs' non-commercial sexual relationships needs to be understood in relation to both sex work and the broader Cambodian sexual culture within which these relationships are embedded...
  26. ncbi The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI)
    M Mofizul Islam
    School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    AIDS Care 24:1496-503. 2012
    ..Adoption of a universal precautionary approach to complement individually tailored assessment of and advice regarding health risk behaviours for IDUs may address this issue...
  27. ncbi Estimating the cost-effectiveness of needle-syringe programs in Australia
    Jisoo A Kwon
    The Kirby Institute, The University of New South Wales, Sydney, Australia
    AIDS 26:2201-10. 2012
    ..To evaluate the impact and cost-effectiveness of needle-syringe programs (NSPs) with respect to HIV and hepatitis C virus (HCV) infections among Australian injecting drug users (IDUs)...
  28. ncbi Factors influencing a self-limiting HIV outbreak among ethnic Vietnamese injecting drug users in Melbourne, Australia
    Peter Higgs
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia
    Qual Health Res 19:1690-701. 2009
    ..Early and effective engagement with participants by health care workers also appears to have played an important role in containing the transmission of HIV within this group of ethnic Vietnamese heroin injectors...
  29. ncbi "Fitness for duty": social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs
    Carla Treloar
    National Centre in HIV Social Research, The University of New South Wales, Sydney, NSW 2052, Australia
    Vaccine 28:5228-36. 2010
    ....
  30. ncbi Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs
    Libby Topp
    Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, Darlinghurst, New South Wales
    Aust N Z J Public Health 32:34-7. 2008
    ..To identify lifetime prevalence and predictors of self-reported injecting-related injuries and diseases (IRID) and/or injecting-related problems (IRP) among a national cross-sectional sample of injecting drug users...
  31. ncbi Có vay có tra (What goes around comes around): culture, risk and vulnerability to blood-borne viruses among ethnic Vietnamese injecting drug users
    Hien Thi Ho
    School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia and Hanoi School of Public Health, Vietnam
    Drug Alcohol Rev 27:420-8. 2008
    ....
  32. ncbi Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009
    Libby Topp
    Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    AIDS 25:835-42. 2011
    ..This study aimed to determine the correlates of HIV infection among PWID; and to examine these correlates over time...
  33. ncbi Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study
    Anna Doab
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst NSW 2010, Australia
    Contemp Clin Trials 30:431-5. 2009
    ....
  34. ncbi Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney
    Joanne Bryant
    National Centre in HIV Social Research, University of New South Wales, Sydney, NSW 2052, Australia
    Drug Alcohol Rev 29:364-70. 2010
    ..This paper examines patterns of equipment acquisition and risk for blood-borne virus transmission among injecting drug users who use pharmacies and needle and syringe programs (NSP) in south-east Sydney...
  35. ncbi Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia
    Jai Nathani
    Viral Hepatitis Epidemiology and Prevention Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia
    Drug Alcohol Rev 29:413-9. 2010
    ..This study attempts to identify and assess cleaning practices in terms of the techniques involved and the social contexts in which cleaning takes place...
  36. ncbi Modelling the hepatitis C virus epidemic in Australia
    Karina Razali
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia
    Drug Alcohol Depend 91:228-35. 2007
    ..This paper updates estimates of HCV incidence and prevalence between 1960 and 2005...
  37. ncbi Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Allison M Salmon
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, NSW, Australia
    Int J Drug Policy 18:46-53. 2007
    ....
  38. ncbi Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection
    Rowena A Bull
    School of Medical Sciences, University of New South Wales, Australia
    PLoS Pathog 7:e1002243. 2011
    ..These results provide the first detailed analysis of early within-host evolution of HCV, indicating strong selective forces limit viral evolution in the acute phase of infection...
  39. ncbi Improving surveillance for acute hepatitis C
    Rachel M Deacon
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales
    Commun Dis Intell Q Rep 35:16-20. 2011
    ....
  40. ncbi Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia
    Lisa Maher
    School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia
    J Gastroenterol Hepatol 19:1114-20. 2004
    ....
  41. ncbi A diagnosis of hepatitis C - insights from a study on patients' experiences
    Carla Treloar
    National Centre in HIV Social Research, The University of New South Wales, Sydney, New South Wales
    Aust Fam Physician 39:589-92. 2010
    ..Previous research has documented patient experiences of hepatitis C virus (HCV) diagnosis to be without sufficient pretest and post-test discussions - health professionals have expressed a need for training in this area...
  42. ncbi Overdose beliefs and management practices among ethnic Vietnamese heroin users in Sydney, Australia
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
    Harm Reduct J 6:6. 2009
    ..Implications for overdose prevention, treatment and management are identified and discussed...
  43. ncbi High Rates of Late HIV Diagnosis Among People Who Inject Drugs Compared to Men Who Have Sex with Men and Heterosexual Men and Women in Australia
    Handan Wand
    Faculty of Medicine, Kirby Institute, University of New South Wales, 45 Beach Street, Coogee, Sydney, NSW, 2034, Australia
    AIDS Behav 17:235-41. 2013
    ..Ongoing prevention efforts need to be coupled with targeted testing and treatment efforts to increase the diagnosis of recent infection in PWID and reduce apparent inequities in access to screening...
  44. ncbi Chlamydia in the Pacific region, the silent epidemic
    Susan J Cliffe
    Perinatal and Reproductive Epidemiology and Research Unit, School Women s and Children s Health, University of New South Wales, Randwick, New South Wales, Australia
    Sex Transm Dis 35:801-6. 2008
    ....
  45. ncbi Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection
    Handan Wand
    The Kirby Institute, University of New South Wales, Sydney, Australia
    BMJ Open 2:e000387. 2012
    ..Conclusions Knowledge of HCV status has important implications for public health and care and treatment. Risk assessment strategies may assist in alerting PWID who are at increased risk of HCV infection to present for testing...
  46. ncbi Selling sex in unsafe spaces: sex work risk environments in Phnom Penh, Cambodia
    Lisa Maher
    The Kirby Institute formerly the National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Harm Reduct J 8:30. 2011
    ..abstract:..
  47. ncbi The Indigenous Resiliency Project: a worked example of community-based participatory research
    Julie Mooney-Somers
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    N S W Public Health Bull 20:112-8. 2009
    ..A commentary on the experience of one health worker involved in the project accompanies the paper...
  48. ncbi 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
    Lisa Maher
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 187:610-2. 2007
  49. ncbi How can hepatitis C be prevented in the long term?
    Pedro Mateu-Gelabert
    Center for Drug Use and HIV Research, National Development Research Institutes, New York City, NY, United States
    Int J Drug Policy 18:338-40. 2007
    ..These studies aim to provide the conceptual basis for developing a new generation of HCV prevention programs to assist both new and experienced IDUs to remain uninfected over the long run...
  50. ncbi Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey
    Carolyn A Day
    Drug Health Services, Central Clinical School, University of Sydney, NSW, Australia
    Drug Alcohol Rev 27:559-61. 2008
  51. ncbi Supervised injecting facilities: how much evidence is enough?
    Lisa Maher
    Drug Alcohol Rev 26:351-3. 2007
  52. ncbi Hepatitis C among intravenous drug users
    Lisa Maher
    Epidemiology 16:423; author reply 424. 2005
  53. ncbi Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen
    Lisa Maher
    Addiction 101:1834-6. 2006
  54. ncbi Applied communitarian ethics for harm reduction: promoting a dialogue within the field
    Craig Fry
    Turning Point Alcohol and Drug Centre Inc and Department of Health Science, Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia
    Drug Alcohol Rev 26:553-5. 2007
    ..This 'discursive authenticity' as Hathaway has called it, can help to define a new territory of authority for drug users as participants in harm reduction policy, practice and research...
  55. ncbi Beyond Olmstead. What the New Freedom Initiative means for long-term care
    Lisa Maher
    Contemp Longterm Care 25:19-21. 2002
  56. ncbi Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions
    Louisa Degenhardt
    Drug Alcohol Rev 27:217-9. 2008
  57. ncbi Beneficiaries get green light to appeal Medicare policies
    Lisa Maher
    Contemp Longterm Care 25:8. 2002
  58. ncbi Drugs, public health and policing in indigenous communities
    Lisa Maher
    Drug Alcohol Rev 23:249-51. 2004